Skip to main content Accessibility help
×
Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-28T22:14:56.554Z Has data issue: false hasContentIssue false

40 - IVF in the Medically Complicated Patient

from PART III - ASSISTED REPRODUCTION

Published online by Cambridge University Press:  04 August 2010

Botros R. M. B. Rizk
Affiliation:
University of South Alabama
Juan A. Garcia-Velasco
Affiliation:
Rey Juan Carlos University School of Medicine,
Hassan N. Sallam
Affiliation:
University of Alexandria School of Medicine
Antonis Makrigiannakis
Affiliation:
University of Crete
Get access

Summary

The majority of women undergoing assisted reproduction are healthy and relatively young. However, the tendency to delay pregnancy to later on in life may mean that some of the patients may present with a concurrent condition that may have implications for in vitro fertilization (IVF), pregnancy, and its outcome. Preparing the couple for pregnancy is an important task, which the infertility specialist has to undertake.

Some of the important issues that may be challenging to the clinician are medical problems that affect a variety of systems. With the increasing survival of cancer patients, many patients are not only satisfied with their cure but are also eager to fulfill their reproductive potential. The patient with endocrine problems such as hyperprolactinemia and hypopituitarism, Cushing's syndrome, and diabetes mellitus have to be addressed prior to assisted conception couples that are discordant for human immunodeficiency virus (HIV) present their own challenge regarding infertility treatment. Couples with sexual dysfunction may also present for assisted conception. Finally, patients at risk for thrombosis could pose tremendous challenges during assisted reproduction treatment and a subsequent pregnancy as discussed in the chapter 45.

Some patients present with gynecologic problems that are either challenging or that impact the IVF outcome. Patients with endometriosis exemplify this scenario as discussed in the chapter 42. Patients with fibroids and hydrosalpynx require surgical treatment prior to IVF as discussed in the chapter 39.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Steegers, EAP and Wildschut, HIJ. Preparing for pregnancy: preconception care. In: Macklon, NS (ed.), IVF in the Medically Complicated Patient: A Guide to Management. Taylor and Francis, London: 2005, Chapter 12, pp. 181–203.Google Scholar
Anderson, RA. The patient with malignant disease. In: Macklon, NS (ed.), IVF in the Medically Complicated Patient: A Guide to Management. Taylor and Francis, London: 2005, Chapter 3, pp. 41–50.Google Scholar
Rueffer, U, Breuer, K, Josting, A, et al. Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment. Ann Oncol 2001; 12:1307–1311.CrossRefGoogle ScholarPubMed
Pal, L, Leykin, L, Schifren, JL, et al. Malignancy may adversely influence the quality and behaviour of oocytes. Hum Reprod 1998; 13:1837–1840.CrossRefGoogle ScholarPubMed
Andersen, RA, Kinniburgh, D, Baird, DT. Preliminary evidence of the use of gonadotrophin releasing-hormone antagonist in superovulation/IVF prior to cancer treatment. Hum Reprod 1999; 14:2665–2668.CrossRefGoogle Scholar
Oktay, K, Buyuk, E, Davis, O, et al. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod 2003; 18:90–95.CrossRefGoogle ScholarPubMed
Sonmezer, M, Oktay, K. Fertility preservation in female patients. Hum Reprod Update 2004; 10:251–266.CrossRefGoogle ScholarPubMed
Ethics Committee of the ASRM. HIV and infertility treatment. Fertil Steril 2002; 77: 218–222.CrossRef
American College of Obstetrics and Gynecologists. HIV: Ethical Guidelines for Obstetricians and Gynecologists, April 2001. ACOG Committee Opinion 255, Washington DC; ACOG, 2001.
The ESHRE Ethics and Law Task Force. Task Force 8: Ethics of medically assisted fertility treatment for HIV positive men and women. Hum Reprod 2004; 19: 2454–6.CrossRef
Sauer, MV. The couple discordant for human immunodeficiency virus. In: Macklon, NS (ed.), IVF in the Medically Complicated Patient: A Guide to Management. Taylor and Francis, London: 2005, Chapter 5, pp. 61–71.Google Scholar
Rizk, B, Dill, R. Counseling HIV patients pursuing infertility investigation and treatment. Hum Reprod 1997;12(3):415–416.CrossRefGoogle ScholarPubMed
Sauer, MV. Sperm washing techniques address the fertility needs of HIV-seropositive men: a clinical review. Reprod Biomed Online 2005; 10:135–140.CrossRefGoogle ScholarPubMed
Semprini, AE, Levi-Seti, P, Bozzo, M, et al. Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 1992; 340:1317–1319.CrossRefGoogle ScholarPubMed
Ola, B, Ledger, L. The obese patient. In: Macklon, NS (ed.), IVF in the Medically Complicated Patient: A Guide To Management. Taylor and Francis, London: 2005, Chapter 7, pp. 87–100.Google Scholar
Wang, JX, Davies, M, Norman, RJ. Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study. BMJ 2000; 321:1320–1321.CrossRefGoogle ScholarPubMed
Wass, P, Waldenstrom, U, Rossner, S, Hellberg, D. An android body fat distribution in females impairs the pregnancy rate of in- vitro fertilization-embryo transfer. Hum Reprod 1997; 12:2057–2060.CrossRefGoogle ScholarPubMed
Blumenfeld, Z. The patient with systemic lupus erythematosus. In: Macklon, Nick S (ed.), IVF in the Medically Complicated Patient: A Guide To Management. Taylor and Francis, London: 2005, Chapter 4, pp. 51–60.Google Scholar
Blumenfeld, Z, Shapiro, D, Shteinberg, M, et al. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic erythematosus treated by chemotherapy. Lupus 2000; 9:1–5.CrossRefGoogle ScholarPubMed
Blumenfeld, Z. Ovarian cryopreservation versus ovarian suppression by GnRH analogues: primum non nocere. Hum Reprod 2004; 19:1924–1925.CrossRefGoogle ScholarPubMed
Guballa, N, Sammaritano, L, Schwartzman, S, et al. Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum 2000; 43:550–556.3.0.CO;2-Y>CrossRefGoogle ScholarPubMed
Rizk, B, Abdalla, H. In vitro fertilization. In Rizk, B, Abdalla, H (Eds.) Infertility and assisted reproductive technology. Oxford: United Kingdom, Health Press, 2008, Chapter 7, pp. 112–114.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×